The past three years, since the first Covid-19 outbreak, have seen healthcare move from 0-60 within a matter of weeks to continue to deliver evidenced based, best practice and safe treatments to our patients. Evidence supporting any particular treatment approach is lacking. Nowhere has this been truer than in the care of patients with both acute and chronic pain. The challenges of assessment, diagnosis and treatment of pain found new struggles in the era of telehealth. Background Pain after a SARS-CoV-2 acute infection (post-COVID pain) is becoming a new healthcare emergency but remains underestimated and most likely undertreated due to a lack of recognition of the phenomenon and knowledge of the underlying pain mechanisms.